Takeaway: Health Expert Addresses Rising Peptide Use, Colorectal Cancer Screening Gaps, and Ebola Preparedness

Last updated: 01/07/2026 23:26

0 Min Read

Dr. Céline Gounder discusses growing concerns about unregulated peptide use, persistent gaps in cancer screening rates, and ongoing Ebola preparedness efforts. Health experts emphasize need for evidence-based approaches to emerging therapies and preventive care.

1 min read|36 words

Key health updates: 1) Unregulated peptides lack FDA safety testing – consult providers before use 2) Cancer screening rates lag among younger eligible adults 3) Hospitals maintain enhanced Ebola protocols from outbreak lessons

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Health Expert Addresses Rising Peptide Use, Colorectal Cancer Screening Gaps, and Ebola Preparedness →

Share This Article

ByProf. Giorgi Pkhakadze

Follow:

Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Takeaway: Health Expert Addresses Rising Peptide Use, Colorectal Cancer Screening Gaps, and Ebola Preparedness

Submit Your Paper →

Gene Therapy Shows Promise for Inherited Cholesterol Disorder in First-in-Human Trial

Teen Drug Use and Binge Drinking Linked to Severe Mental Health Crisis

PFAS ‘Forever Chemicals’ Persist in Ski Wax Rooms Despite Regulatory Bans

Submit Your Paper to GMJ

Company

You Might Also Like